FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
|Articles|June 9, 2022
U.S. Hemp Authority releases version 4.0 draft on its certification program standards
Author(s)Alissa Marrapodi
The U.S. Hemp Authority released a draft Version 4.0 of the standard for its Certification Program for public comment.
Advertisement
The U.S. Hemp Authority released a draft Version 4.0 of the standard for its Certification Program for public comment that includes clarifications on glossary terms, intoxicating cannabinoidproducts, and manufacturing requirements.The
Some of the key changes that deserve publicattention and input are:
- The definitions provided in the Standard’s glossary were changed to reflect the greater understanding of the science and policy behind the hempplant and hemp products.
- Sections outlining the prohibitions on intoxicating compounds being certified by the U.S. HempAuthority were strengthened in 4.0.
- A deletion of mention of any particular firm or company.
- The category that was originally labeled “Manufacturer/Processor” was renamed.
- A category originally labeled “Manufacturer/Processor” was renamed “Manufacturer” to provide more clarity and precision.
Advertisement
Related to this article
Session speakers at SupplySide Global 2026 covered consumer survey data, extraction methods, dosing, and claims for formulators working with functional mushrooms in beverages and foods.
Panelists at SupplySide Global 2026 discussed protein's limits, shifting supplement formats, clean-label expectations, and plainer ingredient communication.
AHPA, CHPA, CRN, and UNPA say placing ODS under the Office of Nutrition Research would add a layer of bureaucracy. NIH is accepting comments through October 28.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
DolCas Biotech is featuring the turmeric-derived ingredient Curcugen in Mānukora’s Mānuka honey and Numin’s cognitive-support drink.
The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.
The Council for Responsible Nutrition says its Morning Consult survey also found that three in four adults use supplements and that cost is the most commonly cited barrier.
Advertisement
Advertisement